Hypertension Treatment in Nigeria Program 2.0
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 10,000
研究概览
简要总结
The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory, Nigeria. This program demonstrated significant improvements in hypertension treatment and control. HTN 2.0 will expand implementation of the HEARTS bundle to 5 new states in 5 geopolitical zones in Nigeria (Abia, Delta, Gombe, Jigawa, and Oyo) while also evaluating sustainment of hypertension control in the Federal Capital Territory.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults (≥18 years old),
- •Elevated blood pressure (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg) documented or measured by a health care professional (e.g., physician, community health extension worker, or community health officer) on two separate occasions or taking a BP-lowering medication, or a history of hypertension.
- •Pregnant women are eligible for this program, or
- •Cognitively impaired adults are eligible for this program..
排除标准
- •This program will not include any of the following special populations:
- •Individuals who are not yet adults (minors): i.e. infants, children, or teenagers <18 years old, or
- •Prisoners or other detained individuals.
研究者
Mark Huffman
William Bowen Professor of Medicine, Professor of Public Health, Co-Director Global Health Center and Global Health Futures
Washington University School of Medicine